Remdesivir in a pregnant patient with COVID-19 pneumonia

Remdesivir in a pregnant patient with COVID-19 pneumonia

Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non...

Full description

Bibliographic Details
Main Authors: Ranadheer Dande, Anum Qureshi, Kia Persaud, Chahat Puri, Sajida Zulfiqar, Shankar Awasthi
Format: Article
Language:English
Published: Greater Baltimore Medical Center 2021-01-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
covid-19 pneumonia
pregnancy
remdesivir
hydroxychloroquine
Online Access:http://dx.doi.org/10.1080/20009666.2020.1857510

Similar Items

Similar Items